Interferon beta-1a Completed Phase 2 Trials for HTLV-1 Associated Myelopathy / Human T-cell lymphotropic virus type I infection / Spinal Cord Diseases Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00001785Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)